To hear about similar clinical trials, please enter your email below
Trial Title:
A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
NCT ID:
NCT05958485
Condition:
Glioblastoma Multiforme
Conditions: Official terms:
Glioblastoma
Conditions: Keywords:
glioblastoma multiforme
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical research can sometimes favor certain demographic groups. Additionally, there is
limited research that delves into the factors that influence participation in clinical
study, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in
glioblastoma multiforme clinical study, as well as the reasons for withdrawal or
discontinuation.
Insights gained from this study will ultimately benefit those with glioblastoma
multiforme who may be invited to participate in clinical trial in the years to come.
Criteria for eligibility:
Study pop:
Patients with glioblastoma multiforme who are actively considering participating in an
observational clinical study, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Diagnosis of glioblastoma multiforme
- No prior treatment for glioblastoma multiforme
- Ability to understand and the willingness to sign a written informed consent
document.
Exclusion Criteria:
- Female patients who are currently pregnant or nursing
- Enrolled in another research study
- Patients who are currently receiving any other investigational drug.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
August 2024
Completion date:
August 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05958485
